IZO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Izotropic Corp. engages in the development and commercialization of IzoView, a CT imaging device with a platform of targeted uses. Its initial plan was to complete the engineering of the first imaging device and seek approval in the USA as a diagnostic device for detecting breast cancers. The company was founded by John M. Boone and Robert Louis Thast on May 19, 2016, and is headquartered in Surrey, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
IZO has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company